BayMark’s focus is on making evidence-based treatments more accessible to those struggling with the disease of addiction. We hope to build on the great foundation built by ORTCA in central Louisiana to do just that.
Lewisville, TX (PRWEB) October 02, 2017
BayMark Health Services announced the acquisition of Opiate Replacement Therapy Center of America (ORTCA). ORTCA will be BayMark’s first opioid treatment provider in Louisiana offering methadone treatment. Under the brand name BAART Programs, the program will continue to provide the high-quality medication-assisted treatment and counseling services that patients have been receiving since 2001.
David K. White, PhD, Chief Executive Officer of BayMark Health Services, commented, “Recently released 2015 data tells us that more than 91 Americans die each day from an opioid overdose, a number that continues to climb as the opioid epidemic intensifies. BayMark’s focus is on making evidence-based treatments more accessible to those struggling with the disease of addiction. We hope to build on the great foundation built by ORTCA in central Louisiana to do just that.”
BayMark Health Services currently operates 55 traditional opioid treatment programs nationwide and 75 programs including different treatment modalities. The BayMark team utilizes best practices within the field of substance abuse disorder and provides national support services to each of its treatment centers to enhance each patient’s experience. To maintain the consistent quality of care that patients have come to expect and provide continuity, the current Treatment Center Director, Tannie Alexander will continue in that role.
For more information on BAART Programs visit: http://www.BAARTPrograms.com.
About BayMark Health Services:
BayMark Health Services, headquartered in Lewisville, Texas, provides medication-assisted treatment for opiate addiction and dependency to thousands of patients nationwide. Our outpatient programs deliver medically supervised treatment, in varied settings and through a variety of modalities, to meet the diverse needs of our patients who struggle with the use of prescription pain medication or other opiates. The BayMark continuum of patient-focused services includes highly structured opioid treatment programs utilizing methadone or buprenorphine and less structured office-based buprenorphine programs, both of which involve counseling as part of an individualized treatment plan. Additional treatment programs consist of ambulatory detoxification services with naltrexone therapy and personalized after care support. For more information, visit: http://www.BayMark.com.